Skip to main content
Clinical Trials/NCT02043704
NCT02043704
Completed
Phase 4

The Effect of Intravenous Acetaminophen on Post-operative Pain and Narcotic Consumption in Vaginal Reconstructive Surgery Patients: A Randomized Controlled Trial

TriHealth Inc.1 site in 1 country100 target enrollmentJanuary 2014

Overview

Phase
Phase 4
Intervention
IV Acetaminophen
Conditions
Post Operative Pain
Sponsor
TriHealth Inc.
Enrollment
100
Locations
1
Primary Endpoint
Total Amount of Narcotic Consumption in the First 24 Hours Post Surgery
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This randomized controlled trial will evaluate the effects of perioperative intravenous (IV) acetaminophen on postoperative narcotic consumption and pain scores in subjects undergoing vaginal reconstructive surgery. One hundred subjects will be randomly assigned to receive either IV acetaminophen or IV placebo. Those in the IV acetaminophen group will receive 1000mg IV every 6 hours for 24 hours beginning prior to anesthesia induction. The control group will receive placebo saline infusions at the same time intervals. All subjects will receive as needed (prn) IV narcotic for additional pain relief. Visual analog scales (VAS) regarding pain will be evaluated at 18 and 24 hours postoperative and immediately prior to discharge. We will also collect total IV narcotic consumption. We hypothesize that subjects receiving IV acetaminophen will have lower VAS scores and decreased total narcotic consumption in comparison to the control group.

Detailed Description

see brief summary

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
August 2016
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Women between the ages of 18 and 70 years
  • Patients of the Division of Urogynecology at Good Samaritan and Bethesda North Hospitals in Cincinnati, Ohio
  • Scheduled to undergo major vaginal reconstruction
  • Must undergo total vaginal hysterectomy, anterior repair, posterior repair, enterocele repair, and intraperitoneal vault suspension. The addition of suburethral sling is not a cause for exclusion.

Exclusion Criteria

  • Allergy to acetaminophen
  • Liver disease (chronic or active)
  • Chronic alcohol use (\>1 drink/day)
  • Bleeding diathesis
  • Renal disease
  • Opiate dependent or daily use
  • History of chronic pain
  • Mental or cognitive disorder preventing patient to accurately verbalize pain levels
  • Undergoing abdominal or laparoscopic procedures at the time of surgery
  • Allergy to hydromorphone

Arms & Interventions

IV Acetaminophen

Subjects will receive a 1000mg dose of IV acetaminophen in 100mL solution every 6 hours for 24 hours. The first dose will be administered prior to anesthesia induction, approximately 30 minutes before skin incision. A total of 4 doses will be given.

Intervention: IV Acetaminophen

Saline

Subjects will receive a 100mL dose of IV saline every 6 hours for 24 hours. The first dose will be administered prior to anesthesia induction, approximately 30 minutes before skin incision. A total of 4 doses will be given.

Intervention: IV Acetaminophen

Outcomes

Primary Outcomes

Total Amount of Narcotic Consumption in the First 24 Hours Post Surgery

Time Frame: 24 hours

Hydromorphone will be administered for breakthrough pain. The total amount consumed in the first 24 hours post surgery will be recorded.

Pain While Active - 18 hr

Time Frame: 18 hours

Post operative pain will be assessed 18 hours after surgery. Pain will be self reported by patients using a 0-100 mm visual analog scale (VAS) with 0 indicating no pain and 100 indicating the worst pain imaginable. A pain score will be collected for pain while active.

Secondary Outcomes

  • Narcotic Associated Side Effects(24 hours)
  • Time to First Rescue Narcotic(24 hours)
  • Time to Ambulation(1800 minutes)

Study Sites (1)

Loading locations...

Similar Trials